
Receptors, Год журнала: 2025, Номер 4(2), С. 9 - 9
Опубликована: Апрель 2, 2025
Bioelectric membrane potentials regulate cellular growth, differentiation, and movement. Disruptions in bioelectric signaling are strongly linked to cancer development, as abnormal ion channel activity can drive tumor progression. In breast cancer, dysfunction neuroreceptor-related pathways play significant roles the cell cycle, epithelial–mesenchymal transition, angiogenesis, inflammation, microenvironment, Neuroreceptors critical not only initiating advancing but also conferring resistance treatments. a key role, with dopamine receptor D2 activation reducing growth by 40% preclinical models, while serotonin has been shown promote transition (EMT), increasing invasiveness. Advances understanding these biological mechanisms could lead more cost-effective less invasive therapeutic strategies treat tumors. This review explores expanding evidence connecting focusing on neuroreceptor pharmacology transformative approach. Examining modulation of bioelectricity through influence progression integrating insights into development offers promising path for addressing treatment challenges improving precision managing aggressive subtypes.
Язык: Английский